Return On Assets in % of Nabriva Therapeutics plc from Q3 2017 to Q2 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Nabriva Therapeutics plc quarterly/annual Return On Assets history and change rate from Q3 2017 to Q2 2023.
  • Nabriva Therapeutics plc Return On Assets for the quarter ending 30 Jun 2023 was -192 %, a 199% decline year-over-year.
  • Nabriva Therapeutics plc annual Return On Assets for 2022 was -114 %, a 98.7% decline from 2021.
  • Nabriva Therapeutics plc annual Return On Assets for 2021 was -57.4 %, a 54.3% increase from 2020.
  • Nabriva Therapeutics plc annual Return On Assets for 2020 was -126 %, a 41.1% decline from 2019.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Nabriva Therapeutics plc Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q2 2023 -192 -127 -199% 01 Apr 2023 30 Jun 2023
Q1 2023 -136 -78.7 -138% 01 Jan 2023 31 Mar 2023
Q4 2022 -114 -56.6 -98.7% 01 Oct 2022 31 Dec 2022
Q3 2022 -76 -8.73 -13% 01 Jul 2022 30 Sep 2022
Q2 2022 -64.1 +13.8 +17.7% 01 Apr 2022 30 Jun 2022
Q1 2022 -57.1 +35.6 +38.4% 01 Jan 2022 31 Mar 2022
Q4 2021 -57.4 +68.3 +54.3% 01 Oct 2021 31 Dec 2021
Q3 2021 -67.3 +49 +42.1% 01 Jul 2021 30 Sep 2021
Q2 2021 -78 +31.7 +28.9% 01 Apr 2021 30 Jun 2021
Q1 2021 -92.7 +18.4 +16.5% 01 Jan 2021 31 Mar 2021
Q4 2020 -126 -36.6 -41.1% 01 Oct 2020 31 Dec 2020
Q3 2020 -116 -23 -24.6% 01 Jul 2020 30 Sep 2020
Q2 2020 -110 +12.8 +10.4% 01 Apr 2020 30 Jun 2020
Q1 2020 -111 +6.52 +5.54% 01 Jan 2020 31 Mar 2020
Q4 2019 -89 +22.9 +20.5% 01 Oct 2019 31 Dec 2019
Q3 2019 -93.3 +14.1 +13.2% 01 Jul 2019 30 Sep 2019
Q2 2019 -122 -47.3 -62.9% 01 Apr 2019 30 Jun 2019
Q1 2019 -118 -42.1 -55.6% 01 Jan 2019 31 Mar 2019
Q4 2018 -112 -29.8 -36.2% 01 Oct 2018 31 Dec 2018
Q3 2018 -107 -32.6 -43.5% 01 Jul 2018 30 Sep 2018
Q2 2018 -75.1 01 Apr 2018 30 Jun 2018
Q1 2018 -75.6 01 Jan 2018 31 Mar 2018
Q4 2017 -82.2 01 Oct 2017 31 Dec 2017
Q3 2017 -74.9 01 Jul 2017 30 Sep 2017

Nabriva Therapeutics plc Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2022 -114 -56.6 -98.7% 01 Jan 2022 31 Dec 2022
2021 -57.4 +68.3 +54.3% 01 Jan 2021 31 Dec 2021
2020 -126 -36.6 -41.1% 01 Jan 2020 31 Dec 2020
2019 -89 +22.9 +20.5% 01 Jan 2019 31 Dec 2019
2018 -112 -29.8 -36.2% 01 Jan 2018 31 Dec 2018
2017 -82.2 01 Jan 2017 31 Dec 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.